CRISPR Therapeutics
Develops genome-editing medicines across blood disorders, liver targets, autoimmune disease, and diabetes.
$57.50
After-hours close−0.20 (−0.35%)
At close$57.70(−2.81%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.06 | — | — |
| Aug 2026 | −$1.19 | −$0.94 | +21.0% |
| May 2026 | −$1.18 | −$1.28 | −8.2% |
| Feb 2026 | −$1.15 | −$1.37 | −19.1% |
| Nov 2025 | −$1.26 | −$1.17 | +7.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Oct 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$1.06 | — | — | $14.8M | — | — |
| Aug 3, 2026 | −$1.19 | −$0.94 | +21.0% | $7.4M | $10.2M | +36.7% |
| May 4, 2026 | −$1.18 | −$1.28 | −8.2% | $6.1M | $1.5M | −76.0% |
| Feb 12, 2026 | −$1.15 | −$1.37 | −19.1% | $4.7M | $864.0K | −81.7% |
| Nov 10, 2025 | −$1.26 | −$1.17 | +7.1% | $9.1M | $889.0K | −90.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 4, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 11, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 21, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Nov 1, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 15, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Jul 29, 2021 | ||||||
| Apr 27, 2021 | ||||||
| Feb 16, 2021 | ||||||
| Oct 28, 2020 | ||||||
| Jul 27, 2020 | ||||||
| Apr 28, 2020 | ||||||
| Feb 12, 2020 | ||||||
| Oct 28, 2019 | ||||||
| Jul 29, 2019 | ||||||
| Apr 29, 2019 | ||||||
| Feb 25, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 8, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 10, 2017 | ||||||
| May 11, 2017 | ||||||
| Mar 10, 2017 | ||||||
| Nov 22, 2016 | ||||||
| Oct 19, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||